Trials / Completed
CompletedNCT01484145
Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
An Unblinded Clinical Trial to Evaluate the Deposition of Terbinafine in the Nail Bed After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Nitric BioTherapeutics, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how much terbinafine is delivered to the nail bed after treatment with a number of modifications to a previously studied method for iontophoretic delivery of terbinafine gel. Iontophoretic delivery involves the use of a small electric charge to deliver drug across skin and nails.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terbinafine HCl | 4% w/w terbinafine HCL gel, single dose, |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-03-01
- Completion
- 2012-04-01
- First posted
- 2011-12-02
- Last updated
- 2012-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01484145. Inclusion in this directory is not an endorsement.